or Try an Advanced Search...

    Buprenorphine/Naloxone Stocks List

    Symbol Grade Name % Change
    AQST D Aquestive Therapeutics, Inc. 7.32
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Amyotrophic Lateral Sclerosis Anaphylaxis Chloroarenes Disease Drugs Epilepsy Gabaa Receptor Positive Allosteric Modulators Neuroendocrine Tumor Neuroendocrine Tumors Opioids Parkinson’s Disease Pharmaceutical Psychoactive Drugs Riluzole Seizure

    Related ETFs - A few ETFs which own one or more of the above listed Buprenorphine/Naloxone stocks.

    Symbol Grade Name Weight
    PTH D Invesco DWA Healthcare Momentum ETF 0.7
    DWAS C PowerShares DWA SmallCap Technical Leaders Portfolio 0.3
    IWC B iShares Microcap ETF 0.04
    VXF C Vanguard Extended Market ETF 0.0
    View all Buprenorphine/Naloxone ETFs...
    Compare ETFs
    Compare IWC to VXF Compare PTH to IWC Compare PTH to VXF

        Buprenorphine/Naloxone Stocks Recent News

        Date Stock Title
        May 2 AQST Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        Apr 30 AQST Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for
        Apr 29 AQST Aquestive stock falls amid Libervant approval, Anaphylm update
        Apr 29 AQST Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
        Apr 27 AQST Aquestive wins FDA approval for anti-seizure therapy Libervant
        Related Industries: Biotechnology
        Related Stock Lists: Amyotrophic Lateral Sclerosis Anaphylaxis Chloroarenes Disease Drugs Epilepsy Gabaa Receptor Positive Allosteric Modulators Neuroendocrine Tumor Neuroendocrine Tumors Opioids Parkinson’s Disease Pharmaceutical Psychoactive Drugs Riluzole Seizure
        Buprenorphine/Naloxone

        Browse All Tags